Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41571-018-0071-6 | DOI Listing |
Pediatr Blood Cancer
January 2025
Department of Nephrology, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
Purpose: Platinum-based chemotherapy is a mainstay of treatment for many childhood cancers but is associated with acute nephrotoxicity and long-term ototoxicity. There is emerging evidence of long-term renal complications. This study aimed to assess the prevalence of chronic kidney disease (CKD) in children treated with platinum chemotherapy (cisplatin and carboplatin) and identify potential risk factors for the development of CKD.
View Article and Find Full Text PDFActa Neurochir (Wien)
October 2024
Department of Neurosurgery, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, Jilin, P.R. China.
Phys Med
November 2024
Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, CH-5232 Villigen, Switzerland; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Radiation Oncology, University Hospital of Zürich, Zürich, Switzerland.
Childs Nerv Syst
November 2024
Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, Brazil.
Purpose: Childhood central nervous system (CNS) tumors tend to have a longer time interval until diagnosis than other pediatric malignancies. The aim is to describe the time to diagnosis among Brazilian pediatric patients treated at a tertiary center and explore associated factors.
Methods: Cross-sectional study; application of questionnaires to parents of children with CNS tumors during outpatient visit or inpatient care.
Childs Nerv Syst
December 2024
Department of Pediatric Neurosurgery, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!